United States · FDA National Drug Code directory
XTAMPZA ER
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 24510-140_fda0989d-9319-4e35-af83-fca1ec66878e
- Product NDC
- 24510-140
- Form
- CAPSULE, EXTENDED RELEASE
- Composition / generic term
- OXYCODONE
- Labeler
- Collegium Pharmaceutical, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20160510
- Source listing expiry
- 20271231
Source-listed ingredients
- OXYCODONE — 36 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (24510-140-10) · 24510-140-10
- 20 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (24510-140-20) · 24510-140-20
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →